Screening and transcriptomic analysis of Crypthecodinium cohnii mutants with high growth and lipid content using the acetyl-CoA carboxylase inhibitor sethoxydim

• DOI: 10.1007/s00253-017-8397-z
• Publication Date: 2017-07-03T02:48:31Z
• Authors: Jing Liu; Guangsheng Pei; Jinjin Diao; Zixi Chen; Liangsen Liu; Lei Chen; Weiwen Zhang
• Keywords: 0301 basic medicine; 0303 health sciences; Cyclohexanones; Gene Expression Profiling; Fatty Acids; Lipid Metabolism; Lipids; High-Throughput Screening Assays; 3. Good health; 03 medical and health sciences; Mutation; Dinoflagellida; Energy Metabolism; Acetyl-CoA Carboxylase

The heterotrophic microalga Crypthecodinium cohnii is well known for its lipid accumulation, with a high proportion of docosahexaenoic acid (DHA). In this study, we report a novel screening approach to obtain mutants of C. cohnii with high growth and lipid content using the acetyl-CoA carboxylase (ACCase) inhibitor sethoxydim. C. cohnii mutants were generated using atmospheric and room-temperature plasma (ARTP) and then screened for two rounds in media supplemented with sethoxydim. These efforts led to the identification of mutant M-1-2, which had 24.32% higher growth and 7.05% higher lipid content than the wild type, demonstrating the effectiveness of the sethoxydim-based screening. Consistently, the M-1-2 mutant displayed a 16.15% increase in ACCase enzymatic activity and 1.53-fold upregulation of its ACCase-encoding gene based on comparative ACCase activity analysis and transcriptomic analysis, respectively. In addition, transcriptomic analysis showed that transcripts involved in fatty acid biosynthesis, energy, central carbohydrate, and amino acid metabolism were upregulated in the mutant compared to the wild type.